Comparison 4. Use of different doses of rimantadine for prophylaxis and treatment of influenza A in the elderly.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinical and laboratory infection	1	54	Risk Ratio (M‐H, Random, 95% CI)	0.93 [0.21, 4.20]
1.1 RMT	1	54	Risk Ratio (M‐H, Random, 95% CI)	0.93 [0.21, 4.20]